Consumer Information
Oraqix
Generic Name: Lidocaine & Prilocaine Periodontal Gel 2.5%/2.5%Date of Approval: December 19, 2003
Manufacturer: Dentsply Pharmaceutical
Treatment for: Periodontal Anesthesia
The U.S. Food and Drug Administration (FDA) has approved Oraqix, a new non-injectable anesthetic for periodontal applications. The anesthetic is delivered to the treatment site without the use of a needle and anesthetizes the site within 30 seconds for a period of approximately 20 minutes.
For further information, please visit www.dentsply.com or see Oraqix Product Labeling
Source: Dentsply International Inc.
| Link to this page |  |
Printable Version |  |
Email Page |  |
Add to my drug list |
Compare Oraqix with other medications for the treatment of:
